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Overview of Federal Technology Transfer*
Lawrence Rudolph**
Introduction
This article is designed to place federal technology transfer policies
and procedures in context by reviewing statutes, pronouncements and
executive orders, which have facilitated the development of both
government patent policy and the transfer of federally-owned
technology.
Federal technology transfer has two components: Government
patent policy, described as the "input" side since it controls federal
agencies' acquisition of rights to inventions, and technology-transfer
policies and authorities that form the "output" side. Some problems
with federal technology transfer stem from the fact that contradictory
policies have been adopted for these two components.
The first part of this article reviews federal technology transfer law
over the past thirteen years; the second illustrates current policies and
procedures of some federal agencies.
Brief History of Federal Technology Transfer
"Input"Side
Long before Senators Bayh and Dole introduced the first version of
their bill in the 95th Congress, many agencies, including the
Department of Defense, the National Institutes of Health (NIH) and
the National Science Foundation (NSF), already allowed contractors to
retain patent rights to their inventions. Other agencies, such as the
Department of Agriculture, the National Aeronautics and Space
*
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Administration and the Department of Energy (DOE), however, had
long-established policies, sometimes required by statute, of claiming
ownership to inventions made with their support, "title in the
government" policies. These agencies licensed the inventions on a nonexclusive, royalty-free basis, thus dedicating these inventions to the
public, or with some exclusivity and subject to royalties.
Despite a Presidential Memorandum on Government Patent Policy
issued by President Kennedy in 1963 and revised by President Nixon
in 1971, there was no uniform government-wide treatment of
inventions. Although a consensus in favor of leaving rights with
inventing organizations slowly developed, agencies continued to go
their separate ways under those memoranda.
Discomfort over the lack of uniformity with respect to government
treatment of inventions, as evidenced by the concern in the academic
research community that Joseph Califano, the Carter Administration's
first Secretary of Health, Education and Welfare, would change NIH's
"title in the contractor" policy, prompted the Bayh-Dole legislation.
Enacted by a "lame duck" Congress and President in December
1980, the Bayh-Dole Act, 1 required agencies to adopt what was then
referred to as a "title in contractor" policy for small business and
nonprofit organizations, such as universities. Thus, small businesses and
nonprofit organizations were given a statutory right to choose to retain
title to inventions made during federally-assisted research and
development (R&D) so long as they were interested in patenting and
attempting to commercialize those inventions.
This policy was based on a belief, supported by evidence gathered
by a federal interagency committee, 2 that private entities, given the
incentives of the patent system, would do a better job of
commercializing inventions than federal agencies.
1 P.L. 96-517, Ch. 18 of 35 U.S.C.
2 Committee on Government Patent Policy of the Federal Council on Science and
Technology, which was established to fulfill an annual reporting requirement in the
1971 Presidential Memorandum on Government Patent Policy, discussed below.
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The Act for the first time established a largely uniform
government-wide policy on the treatment of inventions made during
federally-supported R&D. However, limited flexibility was provided as
illustrated by agencies being able to continue excluding from coverage
of the Act operating contracts for federal government-owned,
contractor-operated (GOCO) facilities. Also, agencies were
empowered, but not required, to leave invention rights with inventors
when awardees did not want them; hence, different agencies adopted.
different practices concerning invention rights.
A little-remembered part of the Act is its endorsement of the 1971
Presidential Memorandum on Government Patent Policy and
authorization of past and future dispositions of invention rights under
it.3 This was deemed necessary by some to provide a statutory basis for
disposing of government property, i.e., patent rights.
Although the "title in contractor" policy of Bayh-Dole was already
that of the NSF and we have, in fact, done everything we can to allow
our contractors and grantees to retain principal legal rights and the
attendant incentives for commercialization, not everyone is happy with
the Act's policy and effects.
Some Members of Congress still believe that things produced with
public funds should be "dedicated to the public", that is, made
available to everyone with no exclusive rights, i.e., no one should profit
as a result of government funding. They fear the situation where "The
government pays the cost of digging the mine, the contractor gets the
gold, and the taxpayer gets the shaft!"
This raises interesting questions: Should no one profit from a
federally-supported activity? Should there be just a little profit? As put
by one bureaucrat, "Do you want us to fund only losers?"
Also, a few academics are unhappy with the Act because it explicitly
encourages universities to commercialize inventions, focusing qn profit
rather than knowledge. Some have wondered if the academy sold its
birthright for a mess of patents.
3
35 U.S.C. § 210(c), amended in 1984 to refer to the 1984 Memorandum,
discussed in the text.
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Those most happy with the Act, of course, are those who conceived
and promoted it, namely, large university and government intellectual
property (IP) specialists.
President Reagan issued a February 1983 "Government Patent
Policy" memorandum, as a result of the Administration's lack of
success in persuading Congress to expand the Act's coverage. Agencies
not prohibited by statute, were directed to treat all contractors, not just
small businesses and nonprofit organizations, in accordance with the
Act, thus expanding coverage to individuals and contractors of all sizes.
Amendments to the Act in 1984 provided that nonprofit GOCOs
would be covered by the Act. 4 These amendments also made the
Department of Commerce (Commerce) the lead agency in U.S.
government patent matters. As such, Commerce promulgated
guidelines that all agencies must observe in disposing of rights to
invention made during federally-supported R&D. 5 Although these
guidelines are mandatory only for awards to small businesses and
nonprofit organizations, agencies, such as NSF, not subject to any
conflicting statute, may apply them to all awardees as directed by the
1983 Presidential Memorandum.
Rules governing inventions made by federal employees, in contrast
with those governing contractors' and grantees' inventions, have been
both uniform and stable. President Truman's 1950 Executive Order,
which presumes that agencies normally will take title to inventions
made by their employees as part of their jobs, still governs. 6 The only
significant change was made in 1986, when section 15 of the Federal
Technology Transfer Act of 1986 (FTTA) directed agencies to allow
employed inventors to patent inventions if agencies do not intend to do
so. 7
4

98 Stat. 3335, 3364-68; Title V of P.L. 98-620.

5

Part 401 of Title 37 C.F.R.
Exec. Order No. 10096, 3 C.F.R. 292 (1949-1953) and Parts 101 and 501 of 37

6

C.F.Rt (Commerce regulations that implement it).
7 Section 15 of the Federal Technology Transfer Act of 1986,
3710(d).

15 U.S.C.
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"Output" Side
Two months before the Bayh-Dole Act was passed, Congress
enacted the Stevenson-Wydler Technology Transfer Act of 1980
(Stevenson-Wydler).8 This is the basic federal technology law. A
principal policy established by that Act is that agencies should ensure
the full use of the results of the nation's federal investment in R&D.
Another is that the government should strive, wherever appropriate, to
transfer federally-owned or -originated technology to both state and
local governments and to the private sector.
Some have questioned whether those policies are consistent with the
"title in the contractor" policy of Bayh-Dole, which removes from
agency control IP rights that would be useful in transferring and
promoting federally-owned or-originated technology. Others wonder
whether adding technology transfer as another mission for every agency
is wise, since this inherently detracts from an agency's ability to focus
on more important roles.
Once again, those who conceived and promoted the legislation, i.e.,
government IP specialists and federal laboratory administrators, were
happy with the importance assigned to their roles.
Stevenson-Wydler required agencies to establish Offices of
Research and Technology Applications (ORTAs) at their federal
laboratories, and to devote a percentage of their R&D budgets to
technology transfer. Another aspect of Stevenson-Wydler was the
establishment of a Center for the Utilization of Federal Technology,
which, in turn, coordinates ORTAs. This Center was established within
Commerce, but, in 1986, was reassigned to what is now the National
Institute of Standards and Technology (NIST).
Few persons outside the federal government, and not many within,
realize that three sections of Stevenson-Wydler established rules for
protecting and licensing federally-owned inventions. 9 As the 1984
Amendments to Bayh-Dole10 did for extramural inventions, these
8

15 U.S.C. % 3701-3714.

9
35 U.S.C. §§ 207-209; implemented by the Department of Commerce
regulation published as Part 404 of Tide 37 C.F.R.
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provisions removed all doubt as to the constitutionality of agencies
patenting and exclusively licensing intramural inventions.
In 1986, the FTTA amended Stevenson-Wydler, but it affects only
federal government-owned, government-operated labs (GOGOs), not
GOCOs. 11 The most important feature of the FTTA was its
authorization of cooperative R&D agreements (CRADAs) between
federal laboratories and nonfederal entities. 12 It also authorized award
programs for federal employees who were responsible for inventions
and required royalty sharing with them whenever an agency retains
ownership. As noted earlier, the FTTA also directs agencies to allow
employees to patent inventions when the agencies themselves do not
patent or otherwise promote commercialization.
To implement the FTTA, President Reagan issued Executive Order
12591, "Facilitating Access to Federal Technology" in April 1987.13 It
directed federal agencies to encourage cooperative research and
technology transfer through their laboratories. It also required
technology access and IP protection to be considered in negotiating
R&D agreements with foreign individuals or governments. This
requirement is important in efforts to persuade other nations to
provide, in law and practice, effective protection for IP and to allow
U.S. scientists and engineers into their laboratories.
The National Competitiveness Technology Transfer Act of 198914
amended the section governing CRADAs15 to authorize DOE GOCO
laboratories to enter into CRADAs on the same basis as its GOGOs. It
also created an exemption from the Freedom of Information Act 16 for
certain categories of information developed during cooperative
10 Supranote4.
11 Another widely-used acronym for a federally-funded R&D center, FFRDC,
coined by the NSF, refers to facilities that derive most of their funding from the

federal government no matter who owns or operates them.
12 15 U.S.C. § 3710(a).
13 Exec. Order No. 12591, 3 C.F.R. 220 (1987) reprinted in 15 U.S.C.A. § 3710
(note).
14 103 Stat. 1674, Nov. 29, 1989; P.L. 101-189.
15 Supra note 12.
16 5 U.S.C. § 552.
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research, permitting federal laboratories to withhold such information
from disclosure for a specified period.
Finally, the American Technology Preeminence Act of 199117
made minor amendments to Stevenson-Wydler, e.g., extending it to
legislative branch agencies and modifying required CRADA terms.
Looking Ahead
Congress is constantly tinkering with the laws governing technology
transfer. In the last Congress, 80 bills were introduced that referenced
or amended the Stevenson-Wydler Act, among 243 measures
introduced that somehow affected technology transfer. What this tells
us and should tell the public as well is that the use of federally-owned
technology to promote economic competitiveness and growth is
certainly very popular, both in Congress and with the Clinton
Administration. Three pending bills are noteworthy.
H.R. 820 was introduced by Rep. Tim Valentine (D-NC) on
February 4, 1993 and was passed by the House of Representatives on
May 19, 1993 (243-167 vote). Because the Senate has passed a similar
measure and President Clinton has indicated his support, H.R. 820 is
likely to be enacted soon. It contains the "National Competitiveness
Act of 1993," ".Manufacturing Technology and Extension Act of 1993"
and "Civilian Technology Development Act of 1993." These proposals
seek to boost the nation's international competitiveness by
strengthening our technology base and fostering the development of
advanced products, particularly in manufacturing.
H.R. 820 would (1) direct the NSF to set up new engineering
centers dedicated to manufacturing R&D, (2) establish an Advanced
Manufacturing Technology Development Program within Commerce
to promote the development and application of advanced
manufacturing technologies and processes, (3) expand Commerce's
Advanced Technology Program to provide greater support for precommercial R&D of generic technologies, (4) strengthen the NIST's
17

106 Stat. 7, Feb. 14, 1992; P.L. 102-245.
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technology transfer program and (5) establish a program to coordinate
the collection of information on foreign science and technology,
"benchmark" foreign R&D capabilities against those in the U.S. and
disseminate this information to U.S. industry. It would also would
establish a National Technology Outreach Program to assist
manufacturers and research centers in upgrading their technology base
by facilitating the sharing of new technology and expertise through an
interactive information and communications system.
- H.R. 1432, the "Department of Energy Laboratory Technology
Act of 1993," would establish missions for DOE R&D laboratories,
provide for review of laboratory effectiveness in realizing such missions
and reorganize and consolidate DOE technology transfer activities.
According to its sponsor, Rep. George Brown (D-CA), the bill has four
key objectives: providing an updated, focused set of missions for the
laboratories; improving the organization of DOE's research,
development and technology transfer functions; enhancing
collaboration between DOE laboratories and industry by streamlining
the technology transfer process; and ensuring that activities of all
federal and DOE laboratories are regularly evaluated and, so far as
possible, coordinated. The DOE supports this bill, and it seems likely
to be enacted in this Session of Congress.
* H.R. 523, the "Technology Transfer Improvements Act of 1993,"
introduced by Rep. Constance A. Morella (R-MD) in January 1993,
would amend Stevenson-Wydler to enhance technology transfer for
works prepared under certain cooperative R&D agreements by allowing
federal agencies to claim copyright in any computer software prepared
in whole or in part by federal employees in the course of work under a
CRADA. This would be the first time that copyright in a "work of the
United States Government" was allowed under U.S. copyright law.
Some industry groups oppose this bill.
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Current Policies and Procedures of Federal Agencies
Technology transfer efforts for federal laboratories are, as described
earlier, prescribed and detailed at some length by the StevensonWydler Act. The Act requires an Office of Research and Technology
Applications to be created at each GOCO and at each GOGO over a
certain size.
All federal agencies are "taxed" to support the Federal Laboratory
Consortium, an interagency group. It helps resolve technology transfer
issues that get raised between government agencies, as well as the terms
of CRADAs. Technology transfer activities themselves vary greatly
from agency to agency, depending on missions and capabilities.
* National Science Foundation. The NSF is barred from operating
any laboratory itself. Its mission is to promote research capability and
education, not to further any particular area of technology. Thus, NSF
has no in-house scientific research or technology transfer efforts.
* The Department of Agriculture. It has a long history of
developing farm-related technology and disseminating it to farmers.
The Agricultural Research Service and the Forest Service have entered
into hundreds of CRADAs since the FTTA became law.
* The Department of Commerce. Commerce has Offices of
Research and Technology Applications in all of its laboratories and has
entered into CRADAs with private industry for research in several

areas. Commerce's NIST, regional Centers for the Transfer of
Manufacturing Technology, and, of course, its Advanced Technology

Program all participate.
0 The Department of Energy. Each DOE laboratory has a
Technology Transfer Office to actively promote inventions and ideas.
DOE's laboratories work overtime to avoid extinction as part of the
"peace dividend," since there are few if any private sector jobs for which
"made atomic bombs" is a valuable resume item. The Cable News
Network reported that DOE labs have entered into over 300 CRADAs.

However, the research funding involved in those agreements amounted
to only 3% of the laboratories' budgets.
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- The National Institutes of Health. The NIH Office of
Technology Transfer promotes and licenses technology developed at all
of its GOCO laboratories. The Public Health Service makes extensive
use of the CRADA authority - but not without controversy. A recent
Washington Post article on a DC-area biotechnology firm that was
among the first to enter into a CRADA with NIH noted that such
partnerships have been criticized because some believe that it is unfair
for participating firms to gain a possible competitive advantage from
government-funded research. 18 The article also reported that CRADAs
are not without private-sector headaches because participating firms
have less influence than they might want over research direction and
must accept complex rules governing conflicts of interest and
proprietary control of knowledge gained from such research.
- The Department of State. Since it supports no scientific research,
it has no technology to transfer; nevertheless, it actively encourages both
scientific and technological cooperation between the U.S. and foreign
agencies, universities and firms. Thus the State Department negotiates
agreements, using both the carrot of technology transfer from federal
agencies and laboratories and the well-publicized stick of trade
sanctions.

18 Genetic Therapy's New Hire Seeks Market for Biotech Products? Washington
Post, June 28, 1993, Washington Business section, at 11.

